TIS tissue therapies limited

relax regarding ce and website, page-17

  1. 224 Posts.
    lightbulb Created with Sketch. 4
    Matt : from the announcement dated 27 March 12, second page :

    "Large scale manufacturing of commercial batches of VitroGro® was required for validation and regulatory approval. The difference between supply and demand only applies to the initial batches of VitroGro® because progressive expiry date extension of each subsequent batch and increasing sales will align production and demand."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.